<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The development of B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> has been reported to occur in recipients of a variety of organ transplants, including some patients who have received an allogeneic bone marrow graft </plain></SENT>
<SENT sid="1" pm="."><plain>In this report, we describe a patient with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who developed a malignant B cell lymphoplasmacytoid proliferation 48 days after undergoing allogeneic marrow transplantation from her HLA-matched MLC-nonreactive brother </plain></SENT>
<SENT sid="2" pm="."><plain>Immunologic studies showed this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> to be a mixed polyclonal and monoclonal proliferation in donor cells </plain></SENT>
<SENT sid="3" pm="."><plain>Virologic studies documented Epstein Barr <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of the cells </plain></SENT>
<SENT sid="4" pm="."><plain>A review of the literature suggests that <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> and treatment of this complication by antithymocyte globulin are related to the development of the <z:e sem="disease" ids="C1333432" disease_type="Neoplastic Process" abbrv="">EBV-related malignancy</z:e> in the EBV-infected B cells of the developing bone marrow graft </plain></SENT>
</text></document>